{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T02:47:02Z","timestamp":1783392422727,"version":"3.54.6"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,4,2]]},"DOI":"10.7759\/cureus.23756","type":"journal-article","created":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T12:27:06Z","timestamp":1648902426000},"source":"Crossref","is-referenced-by-count":4,"title":["Amplatzer Patent Foramen Ovale Occluder Device-Related Complications"],"prefix":"10.7759","author":[{"given":"Beshoy","family":"Iskander","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Anwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Oliveri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kakargias","family":"Fotios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Panday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana  P","family":"Arcia Franchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pousette","family":"Hamid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9149(01)02214-7","article-title":"Incidence of patent ductus arteriosus and patent foramen ovale in normal infants","volume":"89","author":"Connuck D","year":"2002","unstructured":"Connuck D, Sun JP, Super DM, et al.. Incidence of patent ductus arteriosus and patent foramen ovale in normal infants. Am J Cardiol. 2002, 89:244-7. 10.1016\/s0002-9149(01)02214-7","journal-title":"Am J Cardiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy649","article-title":"European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism","volume":"40","author":"Pristipino C","year":"2019","unstructured":"Pristipino C, Sievert H, D'Ascenzo F, et al.. European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism. Eur Heart J. 2019, 40:3182-95. 10.1093\/eurheartj\/ehy649","journal-title":"Eur Heart J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4065\/74.9.862","article-title":"Prevalence of potential risk factors for stroke assessed by transesophageal echocardiography and carotid ultrasonography: the SPARC study. Stroke Prevention: assessment of risk in a community","volume":"74","author":"Meissner I","year":"1999","unstructured":"Meissner I, Whisnant JP, Khandheria BK, et al.. Prevalence of potential risk factors for stroke assessed by transesophageal echocardiography and carotid ultrasonography: the SPARC study. Stroke Prevention: assessment of risk in a community. Mayo Clin Proc. 1999, 74:862-9. 10.4065\/74.9.862","journal-title":"Mayo Clin Proc"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9149(96)00768-0","article-title":"Detection of right to left shunts in decompression sickness in divers","volume":"79","author":"Kerut EK","year":"1997","unstructured":"Kerut EK, Truax WD, Borreson TE, Van Meter KW, Given MB, Giles TD. Detection of right to left shunts in decompression sickness in divers. Am J Cardiol. 1997, 79:377-8. 10.1016\/s0002-9149(96)00768-0","journal-title":"Am J Cardiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198805053181802","article-title":"Prevalence of patent foramen ovale in patients with stroke","volume":"318","author":"Lechat P","year":"1988","unstructured":"Lechat P, Mas JL, Lascault G, et al.. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med. 1988, 318:1148-52. 10.1056\/NEJM198805053181802","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(88)92944-3","article-title":"Patent foramen ovale in young stroke patients","volume":"2","author":"Webster MW","year":"1988","unstructured":"Webster MW, Chancellor AM, Smith HJ, Swift DL, Sharpe DN, Bass NM, Glasgow GL. Patent foramen ovale in young stroke patients. Lancet. 1988, 2:11-2. 10.1016\/s0140-6736(88)92944-3","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(92)91228-v","article-title":"Risk of patent foramen ovale for thromboembolic events in all age groups","volume":"69","author":"de Belder MA","year":"1992","unstructured":"de Belder MA, Tourikis L, Leech G, Camm AJ. Risk of patent foramen ovale for thromboembolic events in all age groups. Am J Cardiol. 1992, 69:1316-20. 10.1016\/0002-9149(92)91228-v","journal-title":"Am J Cardiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-117-6-461","article-title":"Patent foramen ovale as a risk factor for cryptogenic stroke","volume":"117","author":"Di Tullio M","year":"1992","unstructured":"Di Tullio M, Sacco RL, Gopal A, Mohr JP, Homma S. Patent foramen ovale as a risk factor for cryptogenic stroke. Ann Intern Med. 1992, 117:461-5. 10.7326\/0003-4819-117-6-461","journal-title":"Ann Intern Med"},{"key":"ref9","article-title":"Patent foramen ovale and paradoxical embolization: a historical perspective","volume":"66","author":"Lippmann H","year":"1993","unstructured":"Lippmann H, Rafferty T. Patent foramen ovale and paradoxical embolization: a historical perspective. Yale J Biol Med. 1993, 66:11-7.","journal-title":"Yale J Biol Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1707404","article-title":"Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke","volume":"377","author":"S\u00f8ndergaard L","year":"2017","unstructured":"S\u00f8ndergaard L, Kasner SE, Rhodes JF, et al.. Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke. N Engl J Med. 2017, 377:1033-42. 10.1056\/NEJMoa1707404","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1610057","article-title":"Long-term outcomes of patent foramen ovale closure or medical therapy after stroke","volume":"377","author":"Saver JL","year":"2017","unstructured":"Saver JL, Carroll JD, Thaler DE, Smalling RW, MacDonald LA, Marks DS, Tirschwell DL. Long-term outcomes of patent foramen ovale closure or medical therapy after stroke. N Engl J Med. 2017, 377:1022-32. 10.1056\/NEJMoa1610057","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1211716","article-title":"Percutaneous closure of patent foramen ovale in cryptogenic embolism","volume":"368","author":"Meier B","year":"2013","unstructured":"Meier B, Kalesan B, Mattle HP, et al.. Percutaneous closure of patent foramen ovale in cryptogenic embolism. N Engl J Med. 2013, 368:1083-91. 10.1056\/NEJMoa1211716","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1705915","article-title":"Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke","volume":"377","author":"Mas JL","year":"2017","unstructured":"Mas JL, Derumeaux G, Guillon B, et al.. Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke. N Engl J Med. 2017, 377:1011-21. 10.1056\/NEJMoa1705915","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.02.046","article-title":"Cryptogenic stroke and high-risk patent foramen ovale: the DEFENSE-PFO trial","volume":"71","author":"Lee PH","year":"2018","unstructured":"Lee PH, Song JK, Kim JS, et al.. Cryptogenic stroke and high-risk patent foramen ovale: the DEFENSE-PFO trial. J Am Coll Cardiol. 2018, 71:2335-42. 10.1016\/j.jacc.2018.02.046","journal-title":"J Am Coll Cardiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.hlc.2013.12.003","article-title":"Amplatzer PFO occluder device may prevent recurrent stroke in patients with patent foramen ovale and cryptogenic stroke: a meta-analysis of randomised trials","volume":"23","author":"Pandit A","year":"2014","unstructured":"Pandit A, Aryal MR, Pandit AA, Jalota L, Kantharajpur S, Hakim FA, Lee HR. Amplatzer PFO occluder device may prevent recurrent stroke in patients with patent foramen ovale and cryptogenic stroke: a meta-analysis of randomised trials. Heart Lung Circ. 2014, 23:303-8. 10.1016\/j.hlc.2013.12.003","journal-title":"Heart Lung Circ"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/129196","article-title":"Foramen ovale and closure technique with the Amplatzer occluder","volume":"2014","author":"Meier B","year":"2014","unstructured":"Meier B. Foramen ovale and closure technique with the Amplatzer occluder. Scientifica (Cairo). 2014, 2014:129196. 10.1155\/2014\/129196","journal-title":"Scientifica (Cairo)"},{"key":"ref17","article-title":"AMPLATZER septal occluder failure resulting in paradoxical cerebral embolism","volume":"39","author":"Fernando RR","year":"2012","unstructured":"Fernando RR, Koranne KP, Barker CM. AMPLATZER septal occluder failure resulting in paradoxical cerebral embolism. Tex Heart Inst J. 2012, 39:647-52.","journal-title":"Tex Heart Inst J"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.15420\/aer.2014.3.3.168","article-title":"Pathophysiology and management of arrhythmias associated with atrial septal defect and patent foramen ovale","volume":"3","author":"Chubb H","year":"2014","unstructured":"Chubb H, Whitaker J, Williams SE, Head CE, Chung NA, Wright MJ, O'Neill M. Pathophysiology and management of arrhythmias associated with atrial septal defect and patent foramen ovale. Arrhythm Electrophysiol Rev. 2014, 3:168-72. 10.15420\/aer.2014.3.3.168","journal-title":"Arrhythm Electrophysiol Rev"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1017\/S1047951112001424","article-title":"Amplatzer occluder versus CardioSEAL\/STARFlex occluder: a meta-analysis of the efficacy and safety of transcatheter occlusion for patent foramen ovale and atrial septal defect","volume":"23","author":"Li Y","year":"2013","unstructured":"Li Y, Zhou K, Hua Y, et al.. Amplatzer occluder versus CardioSEAL\/STARFlex occluder: a meta-analysis of the efficacy and safety of transcatheter occlusion for patent foramen ovale and atrial septal defect. Cardiol Young. 2013, 23:582-96. 10.1017\/S1047951112001424","journal-title":"Cardiol Young"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2013.07.077","article-title":"Percutaneous closure of patent foramen ovale for cryptogenic stroke: a meta-analysis of randomized controlled trials","volume":"168","author":"Kwong JS","year":"2013","unstructured":"Kwong JS, Lam YY, Yu CM. Percutaneous closure of patent foramen ovale for cryptogenic stroke: a meta-analysis of randomized controlled trials. Int J Cardiol. 2013, 168:4132-8. 10.1016\/j.ijcard.2013.07.077","journal-title":"Int J Cardiol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2013.08.058","article-title":"PFO closure vs. medical therapy in cryptogenic stroke or transient ischemic attack: a systematic review and meta-analysis","volume":"169","author":"Ntaios G","year":"2013","unstructured":"Ntaios G, Papavasileiou V, Makaritsis K, Michel P. PFO closure vs. medical therapy in cryptogenic stroke or transient ischemic attack: a systematic review and meta-analysis. Int J Cardiol. 2013, 169:101-5. 10.1016\/j.ijcard.2013.08.058","journal-title":"Int J Cardiol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.4244\/EIJV9I11A225","article-title":"Updating the evidence on patent foramen ovale closure versus medical therapy in patients with cryptogenic stroke: a systematic review and comprehensive meta-analysis of 2,303 patients from three randomised trials and 2,231 patients from 11 observational studies","volume":"9","author":"Capodanno D","year":"2014","unstructured":"Capodanno D, Milazzo G, Vitale L, Di Stefano D, Di Salvo M, Grasso C, Tamburino C. Updating the evidence on patent foramen ovale closure versus medical therapy in patients with cryptogenic stroke: a systematic review and comprehensive meta-analysis of 2,303 patients from three randomised trials and 2,231 patients from 11 observational studies. EuroIntervention. 2014, 9:1342-9. 10.4244\/EIJV9I11A225","journal-title":"EuroIntervention"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehu292","article-title":"Percutaneous closure of patent foramen ovale in patients with cryptogenic embolism: a network meta-analysis","volume":"36","author":"Stortecky S","year":"2015","unstructured":"Stortecky S, da Costa BR, Mattle HP, et al.. Percutaneous closure of patent foramen ovale in patients with cryptogenic embolism: a network meta-analysis. Eur Heart J. 2015, 36:120-8. 10.1093\/eurheartj\/ehu292","journal-title":"Eur Heart J"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.14503\/THIJ-13-3879","article-title":"Percutaneous closure versus medical therapy alone for cryptogenic stroke patients with a patent foramen ovale: meta-analysis of randomized controlled trials","volume":"41","author":"Pickett CA","year":"2014","unstructured":"Pickett CA, Villines TC, Ferguson MA, Hulten EA. Percutaneous closure versus medical therapy alone for cryptogenic stroke patients with a patent foramen ovale: meta-analysis of randomized controlled trials. Tex Heart Inst J. 2014, 41:357-67. 10.14503\/THIJ-13-3879","journal-title":"Tex Heart Inst J"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009938.pub2","article-title":"Closure versus medical therapy for preventing recurrent stroke in patients with patent foramen ovale and a history of cryptogenic stroke or transient ischemic attack","author":"Li J","year":"2015","unstructured":"Li J, Liu J, Liu M, Zhang S, Hao Z, Zhang J, Zhang C. Closure versus medical therapy for preventing recurrent stroke in patients with patent foramen ovale and a history of cryptogenic stroke or transient ischemic attack. Cochrane Database Syst Rev. 2015, CD009938. 10.1002\/14651858.CD009938.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.12.023","article-title":"Device closure of patent foramen ovale after stroke: pooled analysis of completed randomized trials","volume":"67","author":"Kent DM","year":"2016","unstructured":"Kent DM, Dahabreh IJ, Ruthazer R, et al.. Device closure of patent foramen ovale after stroke: pooled analysis of completed randomized trials. J Am Coll Cardiol. 2016, 67:907-17. 10.1016\/j.jacc.2015.12.023","journal-title":"J Am Coll Cardiol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.carrev.2018.02.014","article-title":"Percutaneous closure of patent foramen ovale vs. medical treatment for patients with history of cryptogenic stroke: a systematic review and meta-analysis of randomized controlled trials","volume":"19","author":"Palaiodimos L","year":"2018","unstructured":"Palaiodimos L, Kokkinidis DG, Faillace RT, Foley TR, Dangas GD, Price MJ, Mastoris I. Percutaneous closure of patent foramen ovale vs. medical treatment for patients with history of cryptogenic stroke: a systematic review and meta-analysis of randomized controlled trials. Cardiovasc Revasc Med. 2018, 19:852-8. 10.1016\/j.carrev.2018.02.014","journal-title":"Cardiovasc Revasc Med"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.2459\/JCM.0000000000000648","article-title":"Closure of patent foramen ovale or medical therapy alone for secondary prevention of cryptogenic cerebrovascular events","volume":"19","author":"Fortuni F","year":"2018","unstructured":"Fortuni F, Crimi G, Leonardi S, et al.. Closure of patent foramen ovale or medical therapy alone for secondary prevention of cryptogenic cerebrovascular events. J Cardiovasc Med (Hagerstown). 2018, 19:373-81. 10.2459\/JCM.0000000000000648","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-018-1334-z","article-title":"Interventional closure vs. medical therapy of patent foramen ovale for secondary prevention of stroke: updated meta-analysis","volume":"108","author":"Vukadinovi\u0107 D","year":"2019","unstructured":"Vukadinovi\u0107 D, Schirmer SH, Vukadinovi\u0107 AN, Ukena C, Scheller B, Mahfoud F, B\u00f6hm M. Interventional closure vs. medical therapy of patent foramen ovale for secondary prevention of stroke: updated meta-analysis. Clin Res Cardiol. 2019, 108:157-66. 10.1007\/s00392-018-1334-z","journal-title":"Clin Res Cardiol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1159\/000507317","article-title":"The closure of patent foramen ovale in preventing subsequent neurological events: a Bayesian network meta-analysis to identify the best device","volume":"49","author":"Varotto L","year":"2020","unstructured":"Varotto L, Bregolin G, Paccanaro M, De Boni A, Bonanno C, Perini F. The closure of patent foramen ovale in preventing subsequent neurological events: a Bayesian network meta-analysis to identify the best device. Cerebrovasc Dis. 2020, 49:124-34. 10.1159\/000507317","journal-title":"Cerebrovasc Dis"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.7326\/M19-3583","article-title":"Residual shunt after patent foramen ovale closure and long-term stroke recurrence: a prospective cohort study","volume":"172","author":"Deng W","year":"2020","unstructured":"Deng W, Yin S, McMullin D, et al.. Residual shunt after patent foramen ovale closure and long-term stroke recurrence: a prospective cohort study. Ann Intern Med. 2020, 172:717-25. 10.7326\/M19-3583","journal-title":"Ann Intern Med"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.4244\/EIJV9I3A61","article-title":"Residual shunt after percutaneous closure of patent foramen ovale with AMPLATZER occluder devices - influence of anatomic features: a transcranial Doppler and intracardiac echocardiography study","volume":"9","author":"Marchese N","year":"2013","unstructured":"Marchese N, Pacilli MA, Inchingolo V, Fanelli R, Loperfido F, Vigna C. Residual shunt after percutaneous closure of patent foramen ovale with AMPLATZER occluder devices - influence of anatomic features: a transcranial Doppler and intracardiac echocardiography study. EuroIntervention. 2013, 9:382-8. 10.4244\/EIJV9I3A61","journal-title":"EuroIntervention"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1186\/2047-783x-16-1-13","article-title":"Risk and fate of residual interatrial shunting after transcatheter closure of patent foramen ovale: a long term follow up study","volume":"16","author":"Hammerstingl C","year":"2011","unstructured":"Hammerstingl C, Bauriedel B, St\u00fcsser C, Momcilovic D, Tuleta I, Nickenig G, Skowasch D. Risk and fate of residual interatrial shunting after transcatheter closure of patent foramen ovale: a long term follow up study. Eur J Med Res. 2011, 16:13-9. 10.1186\/2047-783x-16-1-13","journal-title":"Eur J Med Res"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.20220","article-title":"Thrombosis after septal closure device placement: a review of the current literature","volume":"63","author":"Sherman JM","year":"2004","unstructured":"Sherman JM, Hagler DJ, Cetta F. Thrombosis after septal closure device placement: a review of the current literature. Catheter Cardiovasc Interv. 2004, 63:486-9. 10.1002\/ccd.20220","journal-title":"Catheter Cardiovasc Interv"},{"key":"ref35","article-title":"Thrombus formation during percutaneous closure of an atrial septal defect with an Amplatzer septal occluder","volume":"38","author":"Yorgun H","year":"2011","unstructured":"Yorgun H, Canpolat U, Kaya EB, Aytemir K, Oto A. Thrombus formation during percutaneous closure of an atrial septal defect with an Amplatzer septal occluder. Tex Heart Inst J. 2011, 38:427-30.","journal-title":"Tex Heart Inst J"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2006.05.067","article-title":"Embolic stroke due to a left atrial thrombus two years after placement of an atrial septal defect closure device","volume":"98","author":"Raghu A","year":"2006","unstructured":"Raghu A, Kawalsky D, Feldman M. Embolic stroke due to a left atrial thrombus two years after placement of an atrial septal defect closure device. Am J Cardiol. 2006, 98:1294-6. 10.1016\/j.amjcard.2006.05.067","journal-title":"Am J Cardiol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.5114\/aic.2017.71617","article-title":"Late complications of transcatheter atrial septal defect closure requiring urgent surgery","volume":"13","author":"Kovacevic P","year":"2017","unstructured":"Kovacevic P, Srdanovic I, Ivanovic V, Rajic J, Petrovic N, Velicki L. Late complications of transcatheter atrial septal defect closure requiring urgent surgery. Postepy Kardiol Interwencyjnej. 2017, 13:335-8. 10.5114\/aic.2017.71617","journal-title":"Postepy Kardiol Interwencyjnej"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.21582","article-title":"PFO closure complications from the AGA registry","volume":"72","author":"Amin Z","year":"2008","unstructured":"Amin Z, Hijazi ZM, Bass JL, Cheatham JP, Hellenbrand W, Kleinman CS. PFO closure complications from the AGA registry. Catheter Cardiovasc Interv. 2008, 72:74-9. 10.1002\/ccd.21582","journal-title":"Catheter Cardiovasc Interv"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.euje.2005.08.002","article-title":"Late cardiac tamponade after percutaneous closure of a patent foramen ovale","volume":"6","author":"Christen T","year":"2005","unstructured":"Christen T, Mach F, Didier D, Kalangos A, Verin V, Trindade PT. Late cardiac tamponade after percutaneous closure of a patent foramen ovale. Eur J Echocardiogr. 2005, 6:465-9. 10.1016\/j.euje.2005.08.002","journal-title":"Eur J Echocardiogr"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1097\/MAJ.0b013e318276b071","article-title":"Long-term outcomes after percutaneous patent foramen ovale closure","volume":"346","author":"Nagpal SV","year":"2013","unstructured":"Nagpal SV, Lerakis S, Flueckiger PB, et al.. Long-term outcomes after percutaneous patent foramen ovale closure. Am J Med Sci. 2013, 346:181-6. 10.1097\/MAJ.0b013e318276b071","journal-title":"Am J Med Sci"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2006.02.057","article-title":"Late cardiac perforation after transcatheter closure of patent foramen ovale","volume":"81","author":"Cecconi M","year":"2006","unstructured":"Cecconi M, Quarti A, Bianchini F, Bucari S, Costantini C, Giovagnoni A, Perna GP. Late cardiac perforation after transcatheter closure of patent foramen ovale. Ann Thorac Surg. 2006, 81:e29-30. 10.1016\/j.athoracsur.2006.02.057","journal-title":"Ann Thorac Surg"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2004.12.072","article-title":"Cardiac perforation after device closure of atrial septal defects with the Amplatzer septal occluder","volume":"45","author":"Divekar A","year":"2005","unstructured":"Divekar A, Gaamangwe T, Shaikh N, Raabe M, Ducas J. Cardiac perforation after device closure of atrial septal defects with the Amplatzer septal occluder. J Am Coll Cardiol. 2005, 45:1213-8. 10.1016\/j.jacc.2004.12.072","journal-title":"J Am Coll Cardiol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.019987","article-title":"Relative risk factors for cardiac erosion following transcatheter closure of atrial septal defects: a case-control study","volume":"133","author":"McElhinney DB","year":"2016","unstructured":"McElhinney DB, Quartermain MD, Kenny D, Alboliras E, Amin Z. Relative risk factors for cardiac erosion following transcatheter closure of atrial septal defects: a case-control study. Circulation. 2016, 133:1738-46. 10.1161\/CIRCULATIONAHA.115.019987","journal-title":"Circulation"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/64309-amplatzer-patent-foramen-ovale-occluder-device-related-complications","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:43:43Z","timestamp":1707507823000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/64309-amplatzer-patent-foramen-ovale-occluder-device-related-complications"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,2]]},"references-count":43,"URL":"https:\/\/doi.org\/10.7759\/cureus.23756","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4,2]]}}}